Original Source(s)
Related Content
FDA approves oral dermatomyositis therapy
Phase 3 findings show improvements in physical function and skin disease activity.
August 28, 2026
-
2 min
Serostatus May Modify RA Activity–CV Link
Combined rheumatoid factor and anticitrullinated protein antibody status appeared to modify the association between baseline rheumatoid arthritis disease activity and subsequent cardiovascular events in an international observational cohort.
July 15, 2026
-
4 min